Clinical Trial Update: Effectiveness Study of Dronabinol and BRENDA for the Treatment of Cannabis Withdrawal [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dronabinol and BRENDA for cannabis withdrawal in marijuana dependence; completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Marijuana Dependence

Drugs mentioned

• BRENDA (unknown)
• Dronabinol (dronabinol)

Snippet

Sponsor: University of Pennsylvania | Conditions: Marijuana Dependence | Phase 2 | Status: COMPLETED | Results posted: 2019-07-29